← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2007Last known activity
Aug 15, 2022
Timeline
1920s
- Jun 1, 1923
CHU Brugmann— Founded
Drugs by trial phase (18 distinct, 16 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT05272202Overall official - principal investigatorEarly Phase 1Aug 15, 2022
- NCT03423667Overall official - principal investigatorPhase 2Sep 1, 2018
- NCT02796547Overall official - principal investigatorPhase 2Dec 1, 2017
- NCT03111589Overall official - principal investigatorN/AOct 1, 2016
- NCT02696720Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02312999Overall official - principal investigatorPhase 4Apr 1, 2015
- NCT02314559Overall official - principal investigatorPhase 4Feb 28, 2015
- NCT02319915Overall official - principal investigatorEarly Phase 1Feb 1, 2014
- NCT02258620Overall official - principal investigatorN/AJun 1, 2013
- NCT01849016CollaboratorPhase 3Apr 1, 2013
- NCT02976987Overall official - principal investigatorPhase 2Feb 1, 2013
- NCT02264821Study directorPhase 3Feb 1, 2012
- NCT02908256Overall official - principal investigatorN/AApr 1, 2011
- NCT01081392Overall official - principal investigatorN/AJan 1, 2010
- NCT00456092Overall official - principal investigatorPhase 2Jan 1, 2009
Details
- Founded
- Brussels, BE Jun 1, 1923
- Last known activity
- Aug 15, 2022